Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Jan 4, 2024
Document Date
Jan 4, 2024
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.